CompletedPhase 3NCT02003495

Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine

Studying Meningococcal meningitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Minhai Biotechnology Co., Ltd
Principal Investigator
shengli xia
Henan Provincial Center for Disease Control and Prevention
Intervention
MCV-ACYW135 Vaccine Group(biological)
Enrollment
2195 target
Eligibility
6 years · All sexes
Timeline
2013 – 2014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02003495 on ClinicalTrials.gov

Other trials for Meningococcal meningitis

Additional recruiting or active studies for the same condition.

See all trials for Meningococcal meningitis →

← Back to all trials